The Oncosearch | Oncotarget

Aptamer targeting EGFRvIII mutant hampers its constitutive autophosphorylation and affects migration, invasion and proliferation of glioblastoma cells Research Paper

Simona Camorani, Elvira Crescenzi, David Colecchia, Andrea Carpentieri, Angela Amoresano, Monica Fedele, Mario Chiariello, Laura Cerchia

Published Oct 10, 2015 · Vol. 6, No. 35 · pp. 37570-37587

Interleukin-1 beta transactivates epidermal growth factor receptor via the CXCL1-CXCR2 axis in oral cancer Research Paper

Chia-Huei Lee, Shih-Han Syu, Ko-Jiunn Liu, Pei-Yi Chu, Wen-Chan Yang, Pinpin Lin, Wan-Yu Shieh

Published Oct 9, 2015 · Vol. 6, No. 36 · pp. 38866-38880

Phase II clinical and exploratory biomarker study of dacomitinib in recurrent and/or metastatic esophageal squamous cell carcinoma Clinical Research Papers

Hyo Song Kim, Sung-Moo Kim, Hyunki Kim, Kyoung-Ho Pyo, Jong-Mu Sun, Myung-Ju Ahn, Keunchil Park, Bhumsuk Keam, Nak-Jung Kwon, Hwan Jung Yun, Hoon-Gu Kim, Ik-Joo Chung, Jong Seok Lee, Kyung Hee Lee, Dae Joon Kim, Changâ€‘Geol Lee, Jin Hur, Hyunsoo Chung, Jun Chul Park, Sung Kwan Shin, Sang Kil Lee, Hye Ryun Kim, Yong Wha Moon, Yong Chan Lee, Joo Hang Kim, Soonmyung Paik, Byoung Chul Cho

Published Oct 9, 2015 · Vol. 6, No. 42 · pp. 44971-44984

In vivo imaging of therapy response to a novel Pan-HER antibody mixture using FDG and FLT positron emission tomography Research Paper

Carsten H. Nielsen, Mette M. Jensen, Lotte K. Kristensen, Anna Dahlman, Camilla FrÃ¶hlich, Helle J. Jacobsen, Thomas T. Poulsen, Johan Lantto, Ivan D. Horak, Michael Kragh, Andreas Kjaer

Published Oct 9, 2015 · Vol. 6, No. 35 · pp. 37486-37499

Silibinin enhances the repair of ultraviolet B-induced DNA damage by activating p53-dependent nucleotide excision repair mechanism in human dermal fibroblasts Research Paper

Ruth Guillermo-Lagae, Gagan Deep, Harold Ting, Chapla Agarwal, Rajesh Agarwal

Published Oct 3, 2015 · Vol. 6, No. 37 · pp. 39594-39606

Serine protease inhibitor Kazal type 1 (SPINK1) drives proliferation and anoikis resistance in a subset of ovarian cancers Research Paper

Christine Mehner, Ann L. Oberg, Kimberly R. Kalli, Aziza Nassar, Alexandra Hockla, Devon Pendlebury, Magdalena A. Cichon, Krista M. Goergen, Matthew J. Maurer, Ellen L. Goode, Gary L. Keeney, Aminah Jatoi, MiklÃ³s Sahin-TÃ³th, John A. Copland, Derek C. Radisky, Evette S. Radisky

Published Sep 30, 2015 · Vol. 6, No. 34 · pp. 35737-35754

Simultaneous targeting of 5-LOX-COX and EGFR blocks progression of pancreatic ductal adenocarcinoma Research Paper

Chinthalapally V. Rao, Naveena B. Janakiram, Venkateshwar Madka, Vishal Devarkonda, Misty Brewer, Laura Biddick, Stan Lightfoot, Vernon E. Steele, Altaf Mohammed

Published Sep 28, 2015 · Vol. 6, No. 32 · pp. 33290-33305

Phospho-kinase profile of colorectal tumors guides in the selection of multi-kinase inhibitors Research Paper

Gemma Serrano-Heras, MarÃa Dolores Cuenca-LÃ³pez, Juan Carlos Montero, VerÃ³nica Corrales-Sanchez, Jorge Carlos Morales, Luz-Elena NÃºÃ±ez, Francisco Moris, Atanasio Pandiella, Alberto OcaÃ±a

Published Sep 22, 2015 · Vol. 6, No. 31 · pp. 31272-31283

Wnt/Î²-catenin, an oncogenic pathway targeted by H. pylori in gastric carcinogenesis Review

Xiaowen Song, Na Xin, Wei Wang, Chenghai Zhao

Published Sep 21, 2015 · Vol. 6, No. 34 · pp. 35579-35588

Afatinib, an irreversible ErbB family blocker, with protracted temozolomide in recurrent glioblastoma: A case report Case Report

Jad Alshami, Marie-Christine Guiot, Scott Owen, Petr Kavan, Neil Gibson, Flavio Solca, Agnieszka Cseh, David A. Reardon, Thierry Muanza

Published Sep 21, 2015 · Vol. 6, No. 32 · pp. 34030-34037

EGFRvIII does not affect radiosensitivity with or without gefitinib treatment in glioblastoma cells Research Paper

Nina Struve, Matthias Riedel, Alexander Schulte, Thorsten Rieckmann, Tobias J. Grob, Andreas Gal, Kai Rothkamm, Katrin Lamszus, Cordula Petersen, Ekkehard Dikomey, Malte Kriegs

Published Sep 16, 2015 · Vol. 6, No. 32 · pp. 33867-33877

HER2-specific immunoligands engaging NKp30 or NKp80 trigger NK-cell-mediated lysis of tumor cells and enhance antibody-dependent cell-mediated cytotoxicity Research Paper

Matthias Peipp, Stefanie Derer, Stefan Lohse, Matthias Staudinger, Katja Klausz, Thomas Valerius, Martin Gramatzki, Christian Kellner

Published Sep 15, 2015 · Vol. 6, No. 31 · pp. 32075-32088

The pan-HER family tyrosine kinase inhibitor afatinib overcomes HER3 ligand heregulin-mediated resistance to EGFR inhibitors in non-small cell lung cancer Research Paper

Kimio Yonesaka, Keita Kudo, Satomi Nishida, Takayuki Takahama, Tsutomu Iwasa, Takeshi Yoshida, Kaoru Tanaka, Masayuki Takeda, Hiroyasu Kaneda, Isamu Okamoto, Kazuto Nishio, Kazuhiko Nakagawa

Published Sep 15, 2015 · Vol. 6, No. 32 · pp. 33602-33611

Intracellular activation of EGFR by fatty acid synthase dependent palmitoylation Research Paper

Lakshmi Reddy Bollu, Rajashekhara Reddy Katreddy, Alicia Marie Blessing, Nguyen Pham, Baohui Zheng, Xu Wu, Zhang Weihua

Published Sep 12, 2015 · Vol. 6, No. 33 · pp. 34992-35003

Role of HER2 mutations in refractory metastatic breast cancers: targeted sequencing results in patients with refractory breast cancer Research Paper

Yeon Hee Park, Hyun-Tae Shin, Hae Hyun Jung, Yoon-La Choi, TaeJin Ahn, Kyunghee Park, Aeri Lee, In-Gu Do, Ji-Yeon Kim, Jin Seok Ahn, Woong-Yang Park, Young-Hyuck Im

Published Sep 11, 2015 · Vol. 6, No. 31 · pp. 32027-32038

Concurrent radiotherapy with gefitinib in elderly patients with esophageal squamous cell carcinoma: Preliminary results of a phase II study Clinical Research Papers

Yaping Xu, Yuanda Zheng, Xiaojiang Sun, Xinmin Yu, Jialei Gu, Wei Wu, Gu Zhang, Jinlin Hu, Wenyong Sun, Weimin Mao

Published Sep 10, 2015 · Vol. 6, No. 35 · pp. 38429-38439

miR-200c inhibits breast cancer proliferation by targeting KRAS Research Paper

Cailu Song, Longzhong Liu, Xiaoqing Pei, Xiaoping Liu, Lu Yang, Feng Ye, Xinhua Xie, Jianping Chen, Hailin Tang, Xiaoming Xie

Published Sep 9, 2015 · Vol. 6, No. 33 · pp. 34968-34978

Alterations of biomarker profiles after neoadjuvant chemotherapy in breast cancer: tumor heterogeneity should be taken into consideration Clinical Research Papers

Xingchen Zhou, Junyong Zhang, Haiqin Yun, Ranran Shi, Yan Wang, Wei Wang, Svetlana Bajalica Lagercrantz, Kun Mu

Published Sep 5, 2015 · Vol. 6, No. 34 · pp. 36894-36902

Sur8/Shoc2 promotes cell motility and metastasis through activation of Ras-PI3K signaling Research Paper

Saluja Kaduwal, Woo-Jeong Jeong, Jong-Chan Park, Kug Hwa Lee, Young-Mi Lee, Soung Hoo Jeon, Yong-Beom Lim, Do Sik Min, Kang-Yell Choi

Published Sep 5, 2015 · Vol. 6, No. 32 · pp. 33091-33105

Integrative proteomic and gene expression analysis identify potential biomarkers for adjuvant trastuzumab resistance: analysis from the Fin-her phase III randomized trial Clinical Research Papers

Amir Sonnenblick, Sylvain BrohÃ©e, Debora Fumagalli, FranÃ§oise RothÃ©, Delphine Vincent, Michael Ignatiadis, Christine Desmedt, Roberto Salgado, Nicolas Sirtaine, Sherene Loi, Patrick Neven, Sibylle Loibl, Carsten Denkert, Heikki Joensuu, Martine Piccart, Christos Sotiriou

Published Sep 3, 2015 · Vol. 6, No. 30 · pp. 30306-30316

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

Aptamer targeting EGFRvIII mutant hampers its constitutive autophosphorylation and affects migration, invasion and proliferation of glioblastoma cells Research Paper

Interleukin-1 beta transactivates epidermal growth factor receptor via the CXCL1-CXCR2 axis in oral cancer Research Paper

Phase II clinical and exploratory biomarker study of dacomitinib in recurrent and/or metastatic esophageal squamous cell carcinoma Clinical Research Papers

In vivo imaging of therapy response to a novel Pan-HER antibody mixture using FDG and FLT positron emission tomography Research Paper

Silibinin enhances the repair of ultraviolet B-induced DNA damage by activating p53-dependent nucleotide excision repair mechanism in human dermal fibroblasts Research Paper

Serine protease inhibitor Kazal type 1 (SPINK1) drives proliferation and anoikis resistance in a subset of ovarian cancers Research Paper

Simultaneous targeting of 5-LOX-COX and EGFR blocks progression of pancreatic ductal adenocarcinoma Research Paper

Phospho-kinase profile of colorectal tumors guides in the selection of multi-kinase inhibitors Research Paper

Wnt/Î²-catenin, an oncogenic pathway targeted by H. pylori in gastric carcinogenesis Review

Afatinib, an irreversible ErbB family blocker, with protracted temozolomide in recurrent glioblastoma: A case report Case Report

EGFRvIII does not affect radiosensitivity with or without gefitinib treatment in glioblastoma cells Research Paper

HER2-specific immunoligands engaging NKp30 or NKp80 trigger NK-cell-mediated lysis of tumor cells and enhance antibody-dependent cell-mediated cytotoxicity Research Paper

The pan-HER family tyrosine kinase inhibitor afatinib overcomes HER3 ligand heregulin-mediated resistance to EGFR inhibitors in non-small cell lung cancer Research Paper

Intracellular activation of EGFR by fatty acid synthase dependent palmitoylation Research Paper

Role of HER2 mutations in refractory metastatic breast cancers: targeted sequencing results in patients with refractory breast cancer Research Paper

Concurrent radiotherapy with gefitinib in elderly patients with esophageal squamous cell carcinoma: Preliminary results of a phase II study Clinical Research Papers

miR-200c inhibits breast cancer proliferation by targeting KRAS Research Paper

Alterations of biomarker profiles after neoadjuvant chemotherapy in breast cancer: tumor heterogeneity should be taken into consideration Clinical Research Papers

Sur8/Shoc2 promotes cell motility and metastasis through activation of Ras-PI3K signaling Research Paper

Integrative proteomic and gene expression analysis identify potential biomarkers for adjuvant trastuzumab resistance: analysis from the Fin-her phase III randomized trial Clinical Research Papers

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

Aptamer targeting EGFRvIII mutant hampers its constitutive autophosphorylation and affects migration, invasion and proliferation of glioblastoma cells Research Paper

Interleukin-1 beta transactivates epidermal growth factor receptor via the CXCL1-CXCR2 axis in oral cancer Research Paper

Phase II clinical and exploratory biomarker study of dacomitinib in recurrent and/or metastatic esophageal squamous cell carcinoma Clinical Research Papers

In vivo imaging of therapy response to a novel Pan-HER antibody mixture using FDG and FLT positron emission tomography Research Paper

Silibinin enhances the repair of ultraviolet B-induced DNA damage by activating p53-dependent nucleotide excision repair mechanism in human dermal fibroblasts Research Paper

Serine protease inhibitor Kazal type 1 (SPINK1) drives proliferation and anoikis resistance in a subset of ovarian cancers Research Paper

Simultaneous targeting of 5-LOX-COX and EGFR blocks progression of pancreatic ductal adenocarcinoma Research Paper

Phospho-kinase profile of colorectal tumors guides in the selection of multi-kinase inhibitors Research Paper

Wnt/Î²-catenin, an oncogenic pathway targeted by H. pylori in gastric carcinogenesis Review

Afatinib, an irreversible ErbB family blocker, with protracted temozolomide in recurrent glioblastoma: A case report Case Report

EGFRvIII does not affect radiosensitivity with or without gefitinib treatment in glioblastoma cells Research Paper

HER2-specific immunoligands engaging NKp30 or NKp80 trigger NK-cell-mediated lysis of tumor cells and enhance antibody-dependent cell-mediated cytotoxicity Research Paper

The pan-HER family tyrosine kinase inhibitor afatinib overcomes HER3 ligand heregulin-mediated resistance to EGFR inhibitors in non-small cell lung cancer Research Paper

Intracellular activation of EGFR by fatty acid synthase dependent palmitoylation Research Paper

Role of HER2 mutations in refractory metastatic breast cancers: targeted sequencing results in patients with refractory breast cancer Research Paper

Concurrent radiotherapy with gefitinib in elderly patients with esophageal squamous cell carcinoma: Preliminary results of a phase II study Clinical Research Papers

miR-200c inhibits breast cancer proliferation by targeting KRAS Research Paper

Alterations of biomarker profiles after neoadjuvant chemotherapy in breast cancer: tumor heterogeneity should be taken into consideration Clinical Research Papers

Sur8/Shoc2 promotes cell motility and metastasis through activation of Ras-PI3K signaling Research Paper

Integrative proteomic and gene expression analysis identify potential biomarkers for adjuvant trastuzumab resistance: analysis from the Fin-her phase III randomized trial Clinical Research Papers